Apollomics, Inc. (APLM)
$21.50-1.29%Close
SELLCRISIS · day 4
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $24M
- Beta
- 1.53
- P/E (TTM)
- -2.92
- Short % float
- 0.74%
- Days to cover
- 1.0
- SI change
- +1.6%
- 1W
- -7.61%
- 1M
- -9.89%
- vs SPY 1W
- -8.77%
- vs SPY 1M
- -12.88%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on APLM?
- LOPJLB’s latest quantitative signal on Apollomics, Inc. (APLM) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is APLM in?
- Apollomics, Inc. (APLM) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Apollomics, Inc. (APLM) do?
- Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (…